Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Diabetic Macular Edema
Related studies linked through entity extraction aliases.
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study
- Status
- UNKNOWN
- Phase
- PHASE4
The Effect of Bevacizumab and Ziv-aflibercept in Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Mean Visual Acuity Changes Following Five Injections of Aflibercept
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Imaging Parameters and DME Treatment Response
- Status
- COMPLETED
- Phase
- N/A
Anti-VEGF Treatment for Prevention of PDR/DME
- Status
- COMPLETED
- Phase
- PHASE3
Spectral-domain Optical Coherence Tomography of the Eye
- Status
- UNKNOWN
- Phase
- N/A
Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Injections of Ziv-aflibercept for Macular Diseases
- Status
- COMPLETED
- Phase
- NA
Grid Laser for Diffuse Diabetic Maculopathy
- Status
- COMPLETED
- Phase
- N/A
Study of DS-7080a for the Treatment of Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1
Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
- Status
- WITHDRAWN
- Phase
- PHASE2
SD-OCT Angiography
- Status
- TERMINATED
- Phase
- NA
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
- Status
- COMPLETED
- Phase
- PHASE4
Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Topical Nepafenac as Supplement for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- NA
Variable Interval Versus Set Interval Aflibercept for DME
- Status
- COMPLETED
- Phase
- PHASE4